Taltz in Combination With Enstilar for Psoriasis

Part of paid clinical trials in East Windsor, New Jersey.

Sponsor
Psoriasis Treatment Center of Central New Jersey
Study ID
NCT04372277
Phase
PHASE4
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Enstilar — DRUG
    topical Enstilar foam

Study Details

Enstilar in combination with Taltz for plaque psoriasis.

Key Dates

Start date
Apr 28, 2020
Status verified
Apr 2020
Primary completion
Mar 1, 2021
Completion
Mar 30, 2021

Study Design

Enrollment
25 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Enstilar
    Enstilar foam

Primary Outcome Measure

Body Surface Area 0 or 1 [ Time Frame: 4 weeks ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Psoriasis Treatment Center of Central New JerseyEast WindsorNew Jersey08520
Elise Nelson
[email protected]
609-443-4500
Jerry Bagel, MD (PRINCIPAL_INVESTIGATOR)
David Nieves, MD (SUB_INVESTIGATOR)
Wendy Myers, MD (SUB_INVESTIGATOR)
Alexa Hetzel, PA-C (SUB_INVESTIGATOR)
Brianna Butler, PA-C (SUB_INVESTIGATOR)

Find similar trials in East Windsor, NJ

By condition
Psoriasis
By specialty
DermatologyRheumatologyAutoimmune disease
By research site
Psoriasis Treatment Center of Central New Jersey· East Windsor, NJ

Related Studies